Sign in
4

Changes in Ownership

Vera Therapeutics, Inc. Filed Acc 0001209191-22-049176

Chief Development Officer sold 988 shares at $18.63 ($18,406)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Curley Joanne Chief Development Officer 2022-09-07 Sale −988 $18.63 $18,406 28,797 D: show line 1 in the form
Open-market sales · 988 sh · avg $18.63 · $18,406
Loading xslF345X03/doc4.xml…